EE508 Number Needed to Treat and Cost-per-Event Avoided for Dupilumab Versus Other Asthma Biologics for the Treatment of Moderate-to-Severe Asthma

Saved in:
Bibliographic Details
Published in:Value in health 2024-12, Vol.27 (12), p.S156-S156
Main Authors: Joulain, F, Fourrier, L, Fanelli, F, Wang, Z, Cheng, WH
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
DOI:10.1016/j.jval.2024.10.789